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The tendency of certain individuals to  repeated  attacks  of pneu- 
monia has at  times given rise to doubt whether acquired immunity 
to pneumonia exists.  Considerable evidence, however, can be brought 
forward to show that a  rather high degree of immunity to the pneu- 
mococcus  follows  an  attack  of  pneumonia.  The  crisis  itself  is  a 
striking expression of immunity.  Furthermore, Dochez  1 has  shown 
that the serum of patients convalescing from pneumonia usually con- 
tains protective substances against the homologous type of pneumo- 
coccus, and BlakO has demonstrated precipitins in the serum of cases 
of pneumonia  that  terminate  favorably.  Aside from  these  clinical 
studies,  however, accurate information on  the subject  of immunity 
following pneumonia is meager. 
The experiments herewith reported were performed for the purpose 
of testing the degree of active immunity in monkeys subsequent  to 
an attack of experimental pneumococcus pneumonia. 
Usually the monkey has first been subjected to a pneumonia of one 
of the four pneumococcus types; and following this, the resistance to 
reinfection with a  pneumococcus of the same  type has  been tested. 
Then, as in the study of vaccination with livin$ pneumococci (Paper V), 
tests  for  cross-immunity against one or more of the other types  of 
pneumococcus have been carried out.  The same virulent pneumococci 
were  used  in  these  experiments as in  the  previous studies  and  the 
technique used for producing  experimental pneumonia was identical 
with that already described.  Philippine monkeys (Macacus syrichtus) 
were employed throughout. 
1 Dochez, A. R., J. Exp. Med., 1912, xvi, 665. 
2 Blake, F. G., Arch.  Int. Med., 1918, xxi,  779. 
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Active  Immunity Following Experimental  Pneumococcus Type I 
Pneumonia. 
The first experiment was  a  test  for active immunity following ex- 
perimental  Pneumococcus  Type  I  pneumonia.  It  was  shown  in 
Paper  13  that  experimental  pneumonia  in  monkeys  is  usually  fatal 
when  a  highly virulent pneumococcus is used  for producing  the  dis- 
ease.  By using very minute infecting doses, however, a  certain num- 
ber of recoveries can be obtained.  In  a  series  of Macacus  monkeys 
TABLE  I. 
Experimental Lobar Pneumonia. 
Monkey 
No. 
j, 
75 
77 
Nelght 
gm, 
4,200 
2,600 
Apr. 29. 
Broth culture 
of Pn. I in-  May 15.  X-ray.  Result. 
tratracheally. 
GO° 
0.000I 
0.000001 
Shadow, R. L., 
L. L.* 
Shadow, L. L. 
Clinical pneumonia.  Recovery  by  crisis 
on 12th day. 
Clinical  pneumonia. Recovery  by  lysis 
on llth day. 
* R. L., R. M., R. U.,  etc., indicate lobes of the lung.  The cardiac lobe is 
included as part of the right lower lobe. 
inoculated  intratracheaUy  with  a  virulent  Pneumococcus  Type  I, 
two  recovered.  The  following experiment gives  the  record of  these 
two monkeys. 
Experi~nent/.--Apr. 29,  1919.  Monkey 75 received 0.0001 cc. and Monkey 
77, 0.000001 cc. of broth culture of Pneumococcus Type I  intratracheaUy.  Both 
monkeys promptly developed symptoms and  signs  of  lobar pneumonia,  with 
positive blood cultures  and sharp  leucocyte reactions  (Table I,  Text-fig.  1). 
Both monkeys made uneventful recoveries. 
2 weeks after the recovery of Monkeys 75 and 77, their blood was tested for 
agglutinins  and  protective bodies.  Monkey  77  exhibited no  agglutinins,  but 
did show Some protective bodies; the mouse that received 0.0000001 cc. of cul- 
ture lived 4 days, and the mouse receiving 0.000001 cc. lived 3 days. 
8 Blake, F. G., and Cecil, R. L., J. Exp. Med., 1920, xxxi, 403. II 
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The next step was to  test these  two monkeys for active immunity 
against Pneumococcus Type I. 
E:~peri~nl  2.--May  27,  1919.  Nearly  3  weeks  after  their  recovery from 
pneumonia, Monkeys 75 and 77, with two Mac~s controls were injected intra- 
tracheally with  a  broth  culture  of virulent  Pneumococcus  Type I (the  same 
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strain with which they had been previously infected).  Monkey 75 and its con- 
trol, Monkey 109, each received 0.001 cc. of culture; Monkey 77 and its control, 
Monkey 110, each received 0.000001 cc.  Table II and Text-figs. 2 and 3 show 
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In Table II it will be seen that the two monkeys which had had a 
•  previous attack of Pneumococcus Type I  pneumonia remained well, 
while the two controls developed Pneumococcus Type I  pneumonia. 
Monkey  75  (Text-fig.  2)  showed  a  very slight  temporary  rise  in 
temperature  and  leucocytes, but  was lively and well and displayed 
no symptoms whatever of pneumonia.  The rather high average tem- 
perature was attributed at the time to  the hot  weather, but  subse- 
quently autopsy showed a  chronic p-lmonary tuberculosis.  Monkey 
109, the control to Monkey 75,  was overwhelmed by  the large dose 
(0.001 cc.)  of culture injected and died on the 3rd day of the illness 
with lobar pneumonia and Pneum0coccus Type I  septicemia. 
Monkey 77 (Text-fig.  3) also remained well and showed very little 
temperature  or leucocyte reaction.  The  control,  Monkey  110, de- 
veloped lobar  pneumonia  and  died  on  the  7th  day  of  the  disease 
with a heavy Pneumococcus Type I  septicemia, 
These  experiments corroborate the  evidence  already  at  hand in 
favor of a  high degree of active ~unity  f011ow'mg pneumococcus 
pneumonia.  It wiU be noted that this immunity existed in Monkey 
75  without any evidence of  agglutinh"  s  or protective substances in 
the blood.  The amount of protective substance ..in Monkey 77  was 
almost negligible, yet it also was able to resist reinfection. 
Tests  for Cross-Immunity Following  Pneumococcus Type I Pneumonia. 
In the preceding paper it has been  shown  that vaccination with 
a  living culture of  Pneumococcus Type  I  conferred a  high  degree 
of immunity against pneumonia of the homologous type; and further- 
more,  that by such vaccination a  certain but  variable  amount  of 
cross-immunity was also established against the o~er types of pneu- 
mococcus pneumonia.  It  was  therefore  desirable  to  determine 
whether a similar cross-immunity could be demonstrated ~  monkeys 
that had survived an attack of Pneum0coccus Type I pneumonia. 
Test for Cross-Immunity against Pneumocoecus Type  II Following 
Pneumococcus Type I  Pneumonia.--in the following experiment one 
of the monkeys (No.  75)  that  resisted reinfection with Pneumococ- 
cus  Type I  was  tested  for  cross-immunity  against  Pneumococcus 
Type n.  The same  virulent strain  of Pneumococcus Type II was 692  EXPERI~A~F.~NTAL PNEUMONIA,  VI 
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used in  this  experiment that  had been employed in the vaccination 
experiments. 
g.xperiment 3~mJune 24,  1919.  6 weeks after the attack of Pneumococcus 
Type I pneumonia, Monkey 75 received 0,1 cc. of broth culture of Pneumococcus 
Type II intratracheally.  Monkey 9t served as control, and received the same 
dose of culture.  The results are shown in Table III and Text-figs. 4 and 5. 
Both  monkeys  developed  pneumonia  and  ran  rather  unusually 
long  courses with  final  recovery.  Monkey  75,  however,  continued 
to  run  a  slight  temperature and was  killed July  15,  the 22nd  day 
after  inoculation.  Autopsy  showed  a  chronic  pulmonary  tubercu- 
losis, with early miliary tuberculosis of the various organs.  Monkey 
91,  the  control,  had  had  an  attack  of  spontaneous  Pneumococcus 
Type IV  pneumonia several months before  the  experiment, so was 
not  an  ideal  control.  It  was  the  only  one  available,  however,  at 
this  time,  and  had  to  be  used.  Ordinarily,  an  infecting  dose  as 
large as  the one used in  this  experiment (0.1  cc.)  would have been 
sufficient to kill a  control. 
The  experiment shows  that  an  attack  of  Pneumococcus Type  I 
pneumonia did not afford enough cross-immunity to protect Monkey 
75 from infection with Pneumococcus Type II.  How much of a factor 
the tuberculosis was in this animal and to what extent it affected the 
immunity  it  is  impossible  to  say.  The  tuberculous  process  was 
probably  active  at  the  time  the  immunity  against  Pneumococcus 
Type I  was tested, for the animal was then running an abnormally 
high temperature; yet the presence of tuberculosis apparently did not 
lessen the degree of resistance to Pneumococcus Type I. 
Tests for  Cross-Immunity  against Pneumococcus Type  III  Follow- 
ing Pneumococcus Type I  Pneumonia.--The next step in this series of 
experiments was to test a monkey that had recovered from Pneumo- 
coccus Type I  pneumonia for cross-immunity against Pneumococcus 
Type III.  Monkey  77 was selected for this test. 
Experiment 4.--June 24,  1919.  6  weeks  after recovery from Pneumococcus 
Type I pneumonia, Monkey 77 received 0.1 cc. of broth culture of virulent Pneu- 
mococcus  Tyr~ III intratracheally.  The control, Monkey 115, received the same 
dose at the same time.  Table IV and Text-fig. 6 show the results obtained. TABLE  IV. 
Inoculation  with  Pneumococcus  Type  lit  Following  Pneumococcua  Type  I 
Pneumonia. 
Monkey 
No. 
77 
115 
(COil- 
troD. 
Weight. 
gm, 
2,680 
3,015 
Apr.  29-May 9. 
Experimental 
Pn. I pneu- 
monia. 
May 27. 
Broth culture of 
Pn. I 
intmtracheally. 
Resisted rein- 
fection with 
Pa.I. 
June 23.  June 24. 
Serum tests with  Broth 
Pn. III.  culture  of 
Pn. III 
Agglutl-  Protec-  intra- 
nins.  tion. trachcally. 
CO. 
0  0  0.1 
0.1 
Result, 
No  symptoms 
of  pneumo- 
nia. 
Temporary  fe- 
brile  reac- 
tion with ac- 
celerated 
respiration 
and leucocy- 
tosis. 
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T~T-Fzo.  6,  a  and  b.  Inoculation  with  Pneumococcus  Type III  following 
Pneumococcus  Type  I  pneumonia.  (a)  Monkey  77;  Pneumococcus  Type  I 
pneumonia from Apr. 29  to May 9.  (b)  Monkey 115; control. 
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Monkey 77  remained well and had no symptoms whatever except 
a  moderate  rise  in  leucocytes.  The  temperature  of  the  control 
monkey rose to  I03.4  ° F.  and there was a  sharp leucocyte reaction, 
but  the  blood  culture  remained  sterile  and  the  monkey  did  not 
appear  very  sick.  Evidently  the  control  suffered  nothing  more 
than a  bronchitis or a very small patch of consolidation. 
The Pneumococcus Type III strain used in this experiment at no 
time proved highly virulent for monkeys, though 0.000001  cc.  of  a 
broth  culture would invariably kill  a  mouse.  It  seemed  advisable 
to repeat this test on another monkey using a larger infecting dose of 
Pneumococcus  Type  III.  Accordingly,  another  monkey  (No.  96) 
that  had  recovered  from  Pneumococcus  Type  I  pneumonia  was 
tested  against  Pneumococcus Type Ill.  Monkey 96  had  Pneumo- 
coccus Type I  pneumonia from May 13 to 20.  4 
Experiment 5.--July I, 1919.  Monkey 96, about 6 weeks after the attack of 
Pneumococcus Type I  pneumonia, received I  cc. of broth culture of Pneumo- 
coccus Type III intratracheally  (Table V, Text-fig. 7).  The control,  Monkey 
107, likewise received I cc. of the same culture intratracheally. 
By referring to Table V it will be seen that both monkeys developed 
a  mild interstitial pneumonia, the symptoms of which persisted only 
48  hours.  Neither  monkey presented  a  positive  blood  culture  at 
any  time.  The  temperature  and  leucocyte  curves  for  the  two 
monkeys were stfiklngly alike. 
It cannot be maintained that the vaccinated monkey in this experi- 
ment  showed  any  definite  cross-immunity  against  Pneumococcus 
Type  III.  The  disease ran  a  mild  course in  both  animals  for  the 
probable  reason  that  this  particular  strain  of  Pneumococcus Type 
III  though  virulent  for  mice  possessed  only  slight  virulence  for 
monkeys. 
4  Blake, F. G., and Cecil, R.L., J. Exp. Med., 1920, xxxi, 530, Experiment 3. 598  EXPES~NTAL  PNEUMONIA.  VI 
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T~xT-FIo.  7, a  and b.  Pneumococcus Type IH pneumonia subsequent to 
Pneumococcus  Type I  pneumonia.  (a) Monkey 96;  Pneumococcus  Type  I 
pneumonia from May 13 to 20.  (b) Monkey 107; control. 
Tests/or  Cross-Iramunity  against  Pneumococcus  Type  IV  Following 
Pneumococcus  Type I  Pneumoni, a.--It  has been shown in the previous 
paper that vaccination with a  living Pneumococcus Type I  gave no 
~ppreciable  cross-protection  against  Pneumococcus  Type  IV  pneu- 
monia.  In the present study a  somewhat similar test was made for 
cross-immunity against  Pneumococcus Type  IV  following Pneumo- 
coccus Type I  pneumonia. 
Experitmen~ 6.--July 1, 1919.  Monkey 77, 7 weeks after the attack of Pneu- 
mococcus Type I  pneumonia, and the control,  Monkey 115, each received 0.1 700  EXPERIMENTAL  PNEUMONIA.  VI 
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cc. of Pneumococcus Type IV intratracheally (Table VI)  This was a  virulent 
pneumococcus isolated from a  case of spontaneous lobar pneumonia (Monkey 
97)  and killed a mouse in doses of 0.000001 cc. of broth culture. 
Both  monkeys proved susceptible and ran typical courses of lobar 
pneumonia (Text-fig. 8).  Monkey 77  recovered by crisis on the 7th 
day,  Monkey  115  on  the  9th  day.  Both  animals  had  very  pro- 
nounced leucocyte reactions and positive blood cultures. 
These  two  cases were  about  equally severe.  As  both  recovered, 
it is impossible to say whether Monkey 77  had any cross-immunity 
or not, but the evidence is against such a hypothesis. 
TABLE  VI. 
Inoculaaon with Pneumococc~ Type IV of the  Two  Monkeys Tested in 
Experiment 4. 
Monkey No. 
77 
115 
July 1. 
Serum tests with Pn. 
IV (Strain M 97). 
~  Protection, 
0  0 
0  0 
July 1. 
Broth culture ot 
Pn. IV 
(Strain M 97). 
intratracheally. 
CO. 
0.1 
0.1 
Result. 
Clinical pneumonia.  Recovery  by crisis 
on 7th day. 
Clinical pneumonia.  Recovery  by  crisis 
on 9th day. 
Active Immunity Following an Attack of Pneumococcus Type IV 
Pneumonia. 
The so called Pneumococcus Type IV is not a type in the true sense 
as it consists merely of a large number of pneumococcus strains which 
do  not  fall into  the  three fixed groups  and which usually  have no 
biological  connection  with  one  another.  An  animal  immunized 
against one strain of Pneumococcus Type IV develops agglutinins and 
protective bodies for that particular strain, but as a  general rule this 
serum fails to  agglutinate or protect against other Type IV  strains. 
The question therefore naturally arose whether an attack of Pneu- 
mococcus  Type  IV  pneumonia  would  confer  immunity  against  a 
second  attack  by  the  same  strain,  and  also  whether an  attack  of 702  EXPER~NTAL  PNEUMONIA.  VI 
Pneumococcus Type IV pneumonia would confer any crossdmmunity 
against other strains of Pneumococcus Type IV. 
In order to answer these questions two monkeys that had survived 
attacks  of  Pneumococcus Type  IV  pneumonia were  inoculated  a 
second time with Pneumococcus Type IV as shown in the following 
experiment. 
Experlanent 7.--July 1,  1919.  A large Macacus, Monkey 19, 3 weeks after 
an attack of spontaneous Pneumococcus  Type IV pneumonia, was injected in- 
tratracheally with 0.1  ec. of broth  culture of Pneumococcus Type IV, Strain 
M 97.  At the same time Monkey 111, 3 weeks subsequent to an attack of ex- 
perimental Pneumococcus  Type IV pneumonia (Strain M 97) was also injected 
intratracheally with 0.1 ce. of broth culture of Pneumococcus  Type IV, Strain 
M 97.  Table VII and Text-fig. 9 show the results of this experiment. 
Both monkeys developed Pneumococcus Type IV pneumonia and 
both recovered.  Monkey 19 ran a typical mild course with only one 
positive blood culture.  Monkey 111, inoculated a second time with 
the  identical  strain  injected  1  month  previously,  developed  an 
abortive pneumonia and was sick only 2 or 3 days.  The blood cul- 
ture in this animal was never positive. 
An unexpected sequel to  this experiment presented itself when a 
biological study was  made  of  the  various  Pneumococcus Type  IV 
strains  that  had  been isolated during the  epidemic of spontaneous 
pneumonia in  the  stock  monkeys.  It  was  found  that  the  strain 
originally isolated from Monkey 19 during the attack of spontaneous 
pneumonia and Strain M  97 were agglutinated by the same Pneumo- 
coccus Type IV serum; in other words they belonged to the same bio- 
logical group.  The experiment had been planned to test the amount 
of immunity against Pneumococcus Type IV following an attack of 
Pneumococcus Type IV pneumonia.  Monkey  19  was  to  be  tested 
for cross-immunity against a supposedly heterologous strain, Monkey 
111  for  active immunity against  the homologous strain.  But since 
the pneumococcus isolated from Monkey 19 during its original attack 
of spontaneous pneumonia and Strain M  97 belong to the same sub- 
group of Pneumococcus Type IV, it is apparent that in both monkeys 
we were testing for active immunity against  the homologous strain 
of Pneumococcus Type IV.  Strangely enough both monkeys failed 
to show sufficient immunity to protect them against reinfection with RUSSELL  L.  CECIL  AND  I~RANCIS G.  BLAKE  703 
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the same strain  of Pneumococcus Type IV which had excited in them 
an  attack  of  pneumonia  a  month  previously.  But  although  these 
monkeys were unable  to resist reinfection  with  Pneumococcus Type 
IV,  it  is  clear  that  one  of  them,  Monkey  111,  had  a  considerable 
amount of active immunity--enough  to reduce the second attack to a 
very mild,  abortive pneumonia.  Furthermore,  it is worthy of note 
that the autopsy on  this monkey showed that  it had  never recovered 
completely  from  the  first  attack.  An  old  unresolved  pneumonia 
was  found  in  the  right  upper  lobe,  while  the  fresh  infection  was 
limited  to the right  lower lobe. 
Test for  Cross-Immunity  against Pneumococcus Type  I  Following 
Pneumococcus  Type  1V  Pneumonia.--The  last  experiment  in  this 
series  was undertaken  to  determine  whether  an  attack  of Pneumo- 
coccus Type IV pneumonia would confer any cross-immunlty against 
Pneumococcus Type I pneumonia. 
Experiment 8.--Monkey 115.  Macacus syrichtus, female; weight, 3,015 gin. 
July  1,  1919.  Intratracheal  injection  of 0.1  cc.  of 18 hour  broth  culture  of 
Pneumococcus  Type  IV,  Strain  M  97.  July  2.  Symptoms  of  pneumonia. 
Blood culture positive,  Pneumococcus Type IV.  July 9.  Crisis  and recovery. 
July 26.  Intratracheal  injection  of 0.000001 cc. of 18 hour broth culture  of 
Pneumococcus Type I.  July 27.  Symptoms of pneumonia.  July 29.  Blood 
culture positive (one colony of Pneumococcus Type I in 0.5 cc. of blood).  Aug.  2. 
Crisis and recovery.  The results are shown in Text-fig.  10. 
This  experiment is in line with  the other experiments  on cross-im- 
munity.  The monkey was not sufficiently immune to resist infection 
with  Pneumococcus Type I,  but, in  view of the mild course and  the 
practically  sterile  blood culture,  it  would appear  that  enough  cross- 
immunity was present  to modify favorably the course of the disease. 
Certainly, if an attack of Pneumococcus Type IV pneumonia does not 
stimulate enough protection to prevent a second infection by the same 
strain,  it  could  hardly  be  expected  to  elaborate  an  adequate  cross- 
immunity  against  a  highly virulent  Pneumococcus Type I. 706  EXPERIMENTAL  PNE~ONIA.  VI 
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T~.xT-FzG. 10. Monkey 115.  Pneumococcus Type I  pneumonia subsequent 
to Pneumococcus  Type IV pneumonia. Pneumococcus  Type IV pneumonia  from 
July 1 to 9. 
DISCUSSION. 
The experiments which have been reported prove conclusively that 
in monkeys an attack of Pneumococcus Type I  pneumonia protects 
against a second infection by the homologous type.  It would be desir- 
able  to know how long this immunity lasts, but circumstances have 
not as yet afforded an opportunity for settling this point. 
An attack of Pneumococcus Type I  pneumonia gave little if any 
cross-protection  against  Pneumococcus Type  II  pneumonia.  The 
experiments with Pneumococcus Type III were not altogether satis- 
factory,  as  the  strain  employed  was  not  particularly  virulent  for RUSSELL  L.  CECIL AND  FRANCIS G.  BLAKE  707 
monkeys.  In both the Type II and Type III experiments, however, 
rather large infecting doses were employed, 0.1  cc. of Pneumococcus 
Type II and 0.1  to  1 cc.  of Pnetunococcus Type III.  As in vacci- 
nation with living cultures, a small amount of cross-immunity against 
the other fixed types of pneumococcus is probably always present for 
a certain length of time following experimental Pneumococcus Type I 
pneumonia.  As  in  vaccination with  living  cultures,  however,  the 
degree of cross-immunity depends to some extent on individual varia- 
tion.  The virulence and dose of the invading microorganism are, of 
course,  other  factors  of  great importance.  An  attack  of  Pneumo- 
coccus Type I pneumonia does not appear to induce any higher degree 
of  cross-immunity  than  vaccination  with  a  living  Pneumococcus 
Type I affords. 
It  is  impossible  to  say  why Pneumococcus Type  IV  pneumonia 
fails to protect the monkey against a  second infection by the homol- 
ogous strain when Pneumococcus Type I  confers excellent immunity 
against reinfection.  The highly parasitic character of Pneumococcus 
Type I  may account for this difference.  At any rate,  these obser- 
vations offer little hope for a satisfactory prophylactic vaccine against 
Pneumococcus Type IV pneumonia. 
From the information obtained in this study it would appear pos- 
sible that individuals who suffer from repeated attacks of pneumonia 
are being reinfected from time to time with Pneumococcus Type IV. 
Further  evidence in favor of such a  theory is  afforded by the fact 
that in cases of this kind the disease usually runs a mild course. 
Attention is  again invited to  the inconsistency between tests  for 
protective bodies against the pneumococcus in the serum of monkeys 
and  tests  for active immunity against pneumonia in these animals. 
In  this  respect  the  results  are  in harmony with  those  reported  in 
Papers  IV  5 and  V  where  striking  disagreements  were  sometimes 
noted  in  the  two  methods  for  testing  immunity.  In  the  present 
study, for example, Monkey 75  showed no agglutinins or protective 
bodies against Pneumococcus Type I  in the blood subsequent to the 
attack of Pneumococcus Type I pneumonia; yet when reinjected.with 
Pneumococcus  Type  I  intratracheally,  this  animal  possessed  a 
sufficient degree of active immunity to resist reinfection. 
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CONCLUSIONS. 
1.  Experimental  Pneumococcus  Type  I  pneumonia  in  monkeys 
confers  on  them  an  immunity which protects  them  against  subse- 
quent  infection with  the  homologous type  of  pneumococcus.  The 
duration of this immunity has not been determined. 
2. A certain amount of cross-immunity against the other fixed types 
of pneumococcus pneumonia may or may not be  present  following 
experimental  Pneumococcus  Type  I  pneumonia.  The  degree  of 
cross-immunity is  difficult  to  measure  and  probably  varies  widely 
with the individual monkey. 
3.  Experimental  Pneumococcus Type  IV  pneumonia in monkeys 
confers slight if any protection against subsequent infection with the 
same, or with an homologous strain of Pneumococcus Type IV. 
4.  There  is  no  evidence  in  monkeys  of  cross-immunity against 
Pneumococcus Type IV pneumonia following Pneumococcus Type I 
pneumonia;  and  conversely,  Pneumococcus  Type  IV  pneumonia 
confers no cross-immunity against Pneumococcus Type I  pneumonia. 